Trial record 1 of 1 for:    gt-020
Previous Study | Return to List | Next Study

Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01899859
Recruitment Status : Completed
First Posted : July 16, 2013
Last Update Posted : February 23, 2015
Information provided by (Responsible Party):
Galectin Therapeutics Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2015
  Actual Study Completion Date : February 2015